rs386352319
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000890.5(KCNJ5):c.451G>A(p.Gly151Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G151E) has been classified as Pathogenic.
Frequency
Consequence
NM_000890.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNJ5 | NM_000890.5 | c.451G>A | p.Gly151Arg | missense_variant | Exon 2 of 3 | ENST00000529694.6 | NP_000881.3 | |
KCNJ5 | NM_001354169.2 | c.451G>A | p.Gly151Arg | missense_variant | Exon 3 of 4 | NP_001341098.1 | ||
KCNJ5 | XM_011542810.4 | c.451G>A | p.Gly151Arg | missense_variant | Exon 2 of 3 | XP_011541112.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNJ5 | ENST00000529694.6 | c.451G>A | p.Gly151Arg | missense_variant | Exon 2 of 3 | 1 | NM_000890.5 | ENSP00000433295.1 | ||
KCNJ5 | ENST00000338350.4 | c.451G>A | p.Gly151Arg | missense_variant | Exon 3 of 4 | 1 | ENSP00000339960.4 | |||
KCNJ5 | ENST00000533599.1 | c.451G>A | p.Gly151Arg | missense_variant | Exon 1 of 2 | 1 | ENSP00000434266.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 58
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial hyperaldosteronism type III Pathogenic:2
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
- -
Aldosterone-producing adrenal adenoma, somatic Pathogenic:1
- -
not provided Pathogenic:1
- -
Long QT syndrome Pathogenic:1
This missense change has been observed in individual(s) with clinical features of KCNJ5-related conditions (PMID: 22308486, 24819081). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 151 of the KCNJ5 protein (p.Gly151Arg). This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 91915). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNJ5 protein function. This variant disrupts the p.Gly151 amino acid residue in KCNJ5. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22203740, 22308486). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The p.G151R pathogenic mutation (also known as c.451G>A), located in coding exon 1 of the KCNJ5 gene, results from a G to A substitution at nucleotide position 451. The glycine at codon 151 is replaced by arginine, an amino acid with dissimilar properties. This alteration impacts the highly conserved ion selectivity filter (TIGYGF) located between transmembrane helices S5 and S6. This variant has been identified in multiple individuals with familial hyperaldosteronism type III (FH-III) and was reported to be de novo in several of them (Scholl UI et al. Proc. Natl. Acad. Sci. U.S.A. 2012;109:2533-8; Adachi M et al. Horm Res Paediatr. 2014;82:138-42; Monticone S et al. J Hum Hypertens. 2017;31:776-781). Functional studies suggest G151R leads to increased sodium conductance (Scholl UI et al. Proc. Natl. Acad. Sci. U.S.A. 2012;109:2533-8; Tauber P et al. Endocrinology. 2014;155:1353-62). In addition, internal structural analysis indicates that this variant disrupts the ion channel pore and is expected to eliminate the K+ selectivity of the K+ channel (Tao X et al. Science. 2009;326(5960):1668-74; Whorton MR and MacKinnon R. Cell. 2011;147(1):199-208; Ambry internal data). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at